28 julio 2015
Pharmaceutical firms ‘underinvest’ in long-term research to develop new cancer-fighting drugs due to the greater time and cost required to conduct such research, according to a newly published study.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/8ll2rS0LJgY» height=»1″ width=»1″ alt=»»/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/8ll2rS0LJgY/150728123630.htm
